Iasocholine

Fluorocholine (18F) chloride, the active ingredient in Iasocholine, is an imaging agent presented as an injectable solution for intravenous use. It is used in positron emission tomography (PET) imaging to assess metabolic activity in tumors and other tissues.

GNH USA supplies Iasocholine as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, oncology centres and imaging clinics worldwide.

Iasocholine is employed as a radiotracer in PET imaging for several clinical pathways.

Oncologic PET imaging: helps visualize tumor metabolism and detect malignant lesions. Neurological PET imaging: assesses brain lesions, gliomas and epileptogenic foci. Cardiac PET imaging: evaluates myocardial viability and perfusion abnormalities.

Iasocholine may cause a range of adverse reactions following intravenous administration.

Common Side Effects: - Nausea: mild to moderate discomfort after injection. - Injection site pain: transient soreness at the venipuncture site. - Headache: usually brief and self‑limiting. - Flushing: temporary warmth and redness. - Dizziness: mild light‑headedness. - Transient hypertension: short‑lived rise in blood pressure.

Serious or Rare Side Effects: - Allergic reaction or anaphylaxis: severe hypersensitivity requiring immediate medical attention. - Severe hypotension: sudden drop in blood pressure. - Arrhythmia: irregular heart rhythm. - Radiation‑induced skin injury: localized erythema at high exposure sites. - Renal toxicity: impaired kidney function in susceptible patients. - Severe allergic response: including bronchospasm or angioedema.

Prior to using Iasocholine, clinicians should consider several safety measures.

Renal impairment: assess kidney function and adjust use if necessary. Pregnancy: avoid unless essential, due to ionizing radiation exposure. Breastfeeding: discontinue breastfeeding for an appropriate interval after administration. Allergy to iodine or radiopharmaceuticals: evaluate risk before injection. Concurrent chemotherapy: monitor for additive toxicities. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iasocholine may interact with other agents that affect imaging quality or radiation exposure.

Major Interactions (Avoid): - Therapeutic radiopharmaceuticals: concurrent use can increase total radiation dose. - High‑dose steroids: may reduce tracer uptake and compromise image interpretation. - Iodinated contrast agents: can interfere with PET signal and should be spaced appropriately.

Moderate Interactions (Monitor Closely): - Chemotherapeutic agents: monitor for overlapping toxicities, especially renal effects. - Anticoagulants: observe for bleeding at the injection site. - Other diagnostic agents: schedule to avoid cross‑interference in imaging studies.